Global Oral Polio Vaccines (OPV) Market Research Report 2023

The global Oral Polio Vaccines (OPV) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Oral Polio Vaccines (OPV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Oral Polio Vaccines (OPV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Oral Polio Vaccines (OPV) include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oral Polio Vaccines (OPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Polio Vaccines (OPV).

The Oral Polio Vaccines (OPV) market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oral Polio Vaccines (OPV) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Polio Vaccines (OPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Oral Polio Vaccines (OPV)

1.2 Oral Polio Vaccines (OPV) Segment by Type

1.2.1 Global Oral Polio Vaccines (OPV) Market Value Comparison by Type (2023-2029)

1.2.2 Trivalent OPV

1.2.3 Bivalent OPV

1.3 Oral Polio Vaccines (OPV) Segment by Application

1.3.1 Global Oral Polio Vaccines (OPV) Market Value by Application: (2023-2029)

1.3.2 Public

1.3.3 Private

1.4 Global Oral Polio Vaccines (OPV) Market Size Estimates and Forecasts

1.4.1 Global Oral Polio Vaccines (OPV) Revenue 2018-2029

1.4.2 Global Oral Polio Vaccines (OPV) Sales 2018-2029

1.4.3 Global Oral Polio Vaccines (OPV) Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2018-2023)

2.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Oral Polio Vaccines (OPV) Average Price by Manufacturers (2018-2023)

2.4 Global Oral Polio Vaccines (OPV) Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Oral Polio Vaccines (OPV), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Polio Vaccines (OPV), Product Type & Application

2.7 Oral Polio Vaccines (OPV) Market Competitive Situation and Trends

2.7.1 Oral Polio Vaccines (OPV) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Oral Polio Vaccines (OPV) Players Market Share by Revenue

2.7.3 Global Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Oral Polio Vaccines (OPV) Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Oral Polio Vaccines (OPV) Global Oral Polio Vaccines (OPV) Sales by Region: 2018-2029

3.2.1 Global Oral Polio Vaccines (OPV) Sales by Region: 2018-2023

3.2.2 Global Oral Polio Vaccines (OPV) Sales by Region: 2024-2029

3.3 Global Oral Polio Vaccines (OPV) Global Oral Polio Vaccines (OPV) Revenue by Region: 2018-2029

3.3.1 Global Oral Polio Vaccines (OPV) Revenue by Region: 2018-2023

3.3.2 Global Oral Polio Vaccines (OPV) Revenue by Region: 2024-2029

3.4 North America Oral Polio Vaccines (OPV) Market Facts & Figures by Country

3.4.1 North America Oral Polio Vaccines (OPV) Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Oral Polio Vaccines (OPV) Sales by Country (2018-2029)

3.4.3 North America Oral Polio Vaccines (OPV) Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Oral Polio Vaccines (OPV) Market Facts & Figures by Country

3.5.1 Europe Oral Polio Vaccines (OPV) Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Oral Polio Vaccines (OPV) Sales by Country (2018-2029)

3.5.3 Europe Oral Polio Vaccines (OPV) Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Polio Vaccines (OPV) Market Facts & Figures by Country

3.6.1 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Oral Polio Vaccines (OPV) Sales by Country (2018-2029)

3.6.3 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Oral Polio Vaccines (OPV) Market Facts & Figures by Country

3.7.1 Latin America Oral Polio Vaccines (OPV) Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Oral Polio Vaccines (OPV) Sales by Country (2018-2029)

3.7.3 Latin America Oral Polio Vaccines (OPV) Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Polio Vaccines (OPV) Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2018-2029)

3.8.3 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Oral Polio Vaccines (OPV) Sales by Type (2018-2029)

4.1.1 Global Oral Polio Vaccines (OPV) Sales by Type (2018-2023)

4.1.2 Global Oral Polio Vaccines (OPV) Sales by Type (2024-2029)

4.1.3 Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2018-2029)

4.2 Global Oral Polio Vaccines (OPV) Revenue by Type (2018-2029)

4.2.1 Global Oral Polio Vaccines (OPV) Revenue by Type (2018-2023)

4.2.2 Global Oral Polio Vaccines (OPV) Revenue by Type (2024-2029)

4.2.3 Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2018-2029)

4.3 Global Oral Polio Vaccines (OPV) Price by Type (2018-2029)

5.1 Global Oral Polio Vaccines (OPV) Sales by Application (2018-2029)

5.1.1 Global Oral Polio Vaccines (OPV) Sales by Application (2018-2023)

5.1.2 Global Oral Polio Vaccines (OPV) Sales by Application (2024-2029)

5.1.3 Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2018-2029)

5.2 Global Oral Polio Vaccines (OPV) Revenue by Application (2018-2029)

5.2.1 Global Oral Polio Vaccines (OPV) Revenue by Application (2018-2023)

5.2.2 Global Oral Polio Vaccines (OPV) Revenue by Application (2024-2029)

5.2.3 Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2018-2029)

5.3 Global Oral Polio Vaccines (OPV) Price by Application (2018-2029)

6.1 Sanofi

6.1.1 Sanofi Corporation Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Sanofi Oral Polio Vaccines (OPV) Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.2.4 GSK Oral Polio Vaccines (OPV) Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Bibcol

6.3.1 Bibcol Corporation Information

6.3.2 Bibcol Description and Business Overview

6.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Bibcol Oral Polio Vaccines (OPV) Product Portfolio

6.3.5 Bibcol Recent Developments/Updates

6.4 Serum Institute

6.4.1 Serum Institute Corporation Information

6.4.2 Serum Institute Description and Business Overview

6.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Serum Institute Oral Polio Vaccines (OPV) Product Portfolio

6.4.5 Serum Institute Recent Developments/Updates

6.5 Tiantan Biological

6.5.1 Tiantan Biological Corporation Information

6.5.2 Tiantan Biological Description and Business Overview

6.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio

6.5.5 Tiantan Biological Recent Developments/Updates

6.6 Panacea Biotec Ltd

6.6.1 Panacea Biotec Ltd Corporation Information

6.6.2 Panacea Biotec Ltd Description and Business Overview

6.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio

6.6.5 Panacea Biotec Ltd Recent Developments/Updates

6.7 Bio-Med

6.6.1 Bio-Med Corporation Information

6.6.2 Bio-Med Description and Business Overview

6.6.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Bio-Med Oral Polio Vaccines (OPV) Product Portfolio

6.7.5 Bio-Med Recent Developments/Updates

6.8 Halfkin Bio-Pharmaceuticals

6.8.1 Halfkin Bio-Pharmaceuticals Corporation Information

6.8.2 Halfkin Bio-Pharmaceuticals Description and Business Overview

6.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio

6.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

7.1 Oral Polio Vaccines (OPV) Industry Chain Analysis

7.2 Oral Polio Vaccines (OPV) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Polio Vaccines (OPV) Production Mode & Process

7.4 Oral Polio Vaccines (OPV) Sales and Marketing

7.4.1 Oral Polio Vaccines (OPV) Sales Channels

7.4.2 Oral Polio Vaccines (OPV) Distributors

7.5 Oral Polio Vaccines (OPV) Customers

8.1 Oral Polio Vaccines (OPV) Industry Trends

8.2 Oral Polio Vaccines (OPV) Market Drivers

8.3 Oral Polio Vaccines (OPV) Market Challenges

8.4 Oral Polio Vaccines (OPV) Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Oral Polio Vaccines (OPV) Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Oral Polio Vaccines (OPV) Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Oral Polio Vaccines (OPV) Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Oral Polio Vaccines (OPV) Sales (M Doses) of Key Manufacturers (2018-2023)

    Table 5. Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Oral Polio Vaccines (OPV) Average Price (USD/Doses) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Oral Polio Vaccines (OPV), Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Oral Polio Vaccines (OPV), Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Oral Polio Vaccines (OPV), Product Type & Application

    Table 12. Global Key Manufacturers of Oral Polio Vaccines (OPV), Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Polio Vaccines (OPV) as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Oral Polio Vaccines (OPV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Oral Polio Vaccines (OPV) Sales by Region (2018-2023) & (M Doses)

    Table 18. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2018-2023)

    Table 19. Global Oral Polio Vaccines (OPV) Sales by Region (2024-2029) & (M Doses)

    Table 20. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2024-2029)

    Table 21. Global Oral Polio Vaccines (OPV) Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2018-2023)

    Table 23. Global Oral Polio Vaccines (OPV) Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2024-2029)

    Table 25. North America Oral Polio Vaccines (OPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Oral Polio Vaccines (OPV) Sales by Country (2018-2023) & (M Doses)

    Table 27. North America Oral Polio Vaccines (OPV) Sales by Country (2024-2029) & (M Doses)

    Table 28. North America Oral Polio Vaccines (OPV) Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Oral Polio Vaccines (OPV) Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Oral Polio Vaccines (OPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Oral Polio Vaccines (OPV) Sales by Country (2018-2023) & (M Doses)

    Table 32. Europe Oral Polio Vaccines (OPV) Sales by Country (2024-2029) & (M Doses)

    Table 33. Europe Oral Polio Vaccines (OPV) Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Oral Polio Vaccines (OPV) Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2018-2023) & (M Doses)

    Table 37. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2024-2029) & (M Doses)

    Table 38. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Oral Polio Vaccines (OPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Oral Polio Vaccines (OPV) Sales by Country (2018-2023) & (M Doses)

    Table 42. Latin America Oral Polio Vaccines (OPV) Sales by Country (2024-2029) & (M Doses)

    Table 43. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Country (2018-2023) & (M Doses)

    Table 47. Middle East & Africa Oral Polio Vaccines (OPV) Sales by Country (2024-2029) & (M Doses)

    Table 48. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Oral Polio Vaccines (OPV) Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Type (2018-2023)

    Table 51. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Type (2024-2029)

    Table 52. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2018-2023)

    Table 53. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2024-2029)

    Table 54. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2018-2023)

    Table 57. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2024-2029)

    Table 58. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Type (2018-2023)

    Table 59. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Type (2024-2029)

    Table 60. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Application (2018-2023)

    Table 61. Global Oral Polio Vaccines (OPV) Sales (M Doses) by Application (2024-2029)

    Table 62. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2018-2023)

    Table 63. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2024-2029)

    Table 64. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Oral Polio Vaccines (OPV) Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2018-2023)

    Table 67. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2024-2029)

    Table 68. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Application (2018-2023)

    Table 69. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Application (2024-2029)

    Table 70. Sanofi Corporation Information

    Table 71. Sanofi Description and Business Overview

    Table 72. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 73. Sanofi Oral Polio Vaccines (OPV) Product

    Table 74. Sanofi Recent Developments/Updates

    Table 75. GSK Corporation Information

    Table 76. GSK Description and Business Overview

    Table 77. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 78. GSK Oral Polio Vaccines (OPV) Product

    Table 79. GSK Recent Developments/Updates

    Table 80. Bibcol Corporation Information

    Table 81. Bibcol Description and Business Overview

    Table 82. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 83. Bibcol Oral Polio Vaccines (OPV) Product

    Table 84. Bibcol Recent Developments/Updates

    Table 85. Serum Institute Corporation Information

    Table 86. Serum Institute Description and Business Overview

    Table 87. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 88. Serum Institute Oral Polio Vaccines (OPV) Product

    Table 89. Serum Institute Recent Developments/Updates

    Table 90. Tiantan Biological Corporation Information

    Table 91. Tiantan Biological Description and Business Overview

    Table 92. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 93. Tiantan Biological Oral Polio Vaccines (OPV) Product

    Table 94. Tiantan Biological Recent Developments/Updates

    Table 95. Panacea Biotec Ltd Corporation Information

    Table 96. Panacea Biotec Ltd Description and Business Overview

    Table 97. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 98. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product

    Table 99. Panacea Biotec Ltd Recent Developments/Updates

    Table 100. Bio-Med Corporation Information

    Table 101. Bio-Med Description and Business Overview

    Table 102. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 103. Bio-Med Oral Polio Vaccines (OPV) Product

    Table 104. Bio-Med Recent Developments/Updates

    Table 105. Halfkin Bio-Pharmaceuticals Corporation Information

    Table 106. Halfkin Bio-Pharmaceuticals Description and Business Overview

    Table 107. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 108. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product

    Table 109. Halfkin Bio-Pharmaceuticals Recent Developments/Updates

    Table 110. Key Raw Materials Lists

    Table 111. Raw Materials Key Suppliers Lists

    Table 112. Oral Polio Vaccines (OPV) Distributors List

    Table 113. Oral Polio Vaccines (OPV) Customers List

    Table 114. Oral Polio Vaccines (OPV) Market Trends

    Table 115. Oral Polio Vaccines (OPV) Market Drivers

    Table 116. Oral Polio Vaccines (OPV) Market Challenges

    Table 117. Oral Polio Vaccines (OPV) Market Restraints

    Table 118. Research Programs/Design for This Report

    Table 119. Key Data Information from Secondary Sources

    Table 120. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Oral Polio Vaccines (OPV)

    Figure 2. Global Oral Polio Vaccines (OPV) Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Oral Polio Vaccines (OPV) Market Share by Type in 2022 & 2029

    Figure 4. Trivalent OPV Product Picture

    Figure 5. Bivalent OPV Product Picture

    Figure 6. Global Oral Polio Vaccines (OPV) Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Oral Polio Vaccines (OPV) Market Share by Application in 2022 & 2029

    Figure 8. Public

    Figure 9. Private

    Figure 10. Global Oral Polio Vaccines (OPV) Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 11. Global Oral Polio Vaccines (OPV) Market Size (2018-2029) & (US$ Million)

    Figure 12. Global Oral Polio Vaccines (OPV) Sales (2018-2029) & (M Doses)

    Figure 13. Global Oral Polio Vaccines (OPV) Average Price (USD/Doses) & (2018-2029)

    Figure 14. Oral Polio Vaccines (OPV) Report Years Considered

    Figure 15. Oral Polio Vaccines (OPV) Sales Share by Manufacturers in 2022

    Figure 16. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers in 2022

    Figure 17. The Global 5 and 10 Largest Oral Polio Vaccines (OPV) Players: Market Share by Revenue in 2022

    Figure 18. Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 19. Global Oral Polio Vaccines (OPV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 20. North America Oral Polio Vaccines (OPV) Sales Market Share by Country (2018-2029)

    Figure 21. North America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2018-2029)

    Figure 22. U.S. Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 23. Canada Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Europe Oral Polio Vaccines (OPV) Sales Market Share by Country (2018-2029)

    Figure 25. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Country (2018-2029)

    Figure 26. Germany Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. France Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. U.K. Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Italy Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Russia Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Region (2018-2029)

    Figure 32. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Region (2018-2029)

    Figure 33. China Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Japan Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. South Korea Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. India Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Australia Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Taiwan Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Indonesia Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Thailand Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Malaysia Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Philippines Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Country (2018-2029)

    Figure 44. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Country (2018-2029)

    Figure 45. Mexico Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Brazil Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Argentina Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Oral Polio Vaccines (OPV) Sales Market Share by Country (2018-2029)

    Figure 49. Middle East & Africa Oral Polio Vaccines (OPV) Revenue Market Share by Country (2018-2029)

    Figure 50. Turkey Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. U.A.E Oral Polio Vaccines (OPV) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Global Sales Market Share of Oral Polio Vaccines (OPV) by Type (2018-2029)

    Figure 54. Global Revenue Market Share of Oral Polio Vaccines (OPV) by Type (2018-2029)

    Figure 55. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Type (2018-2029)

    Figure 56. Global Sales Market Share of Oral Polio Vaccines (OPV) by Application (2018-2029)

    Figure 57. Global Revenue Market Share of Oral Polio Vaccines (OPV) by Application (2018-2029)

    Figure 58. Global Oral Polio Vaccines (OPV) Price (USD/Doses) by Application (2018-2029)

    Figure 59. Oral Polio Vaccines (OPV) Value Chain

    Figure 60. Oral Polio Vaccines (OPV) Production Process

    Figure 61. Channels of Distribution (Direct Vs Distribution)

    Figure 62. Distributors Profiles

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed